Prevention of venous thrombosis after elective hip surgery.
Turpie
A G
AG
McMaster University and Hamilton Health Sciences Corporation, General Division, Ontario, Canada.
Kher
A
A
D000925:Anticoagulants / Q000008:administration & dosage*; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D017558:Elective Surgical Procedures; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D019990:Perioperative Care / Q000379:methods; D011183:Postoperative Complications / Q000517:prevention & control; D011379:Prognosis; D011655:Pulmonary Embolism / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D015996:Survival Rate; D013924:Thrombophlebitis / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight